Prevention of contrast-induced acute kidney injury in patients undergoing percutaneous coronary intervention
Marco Legnazzi, Federica Agnello, Davide Capodanno
Abstract
Intravascular administration of contrast media is an irreplaceable step of percutaneous coronary intervention. Since the latter is a very common procedure, contrast‑induced acute kidney injury (CI‑AKI) has become one of the most frequent causes of acute nephropathy, and a relevant prognostic impact of CI‑AKI has been observed. Some patient comorbidities and procedural characteristics have been identified as key risk factors of CI‑AKI. In this review, we discuss current evidence and future research directions on CI‑AKI prevention in patients undergoing percutaneous coronary intervention.
Topics & Concepts
MedicinePercutaneous coronary interventionAcute kidney injuryContrast-induced nephropathyPercutaneousCardiologyIntensive care medicineInternal medicineIntervention (counseling)Myocardial infarctionPsychiatryAcute Kidney Injury ResearchChronic Kidney Disease and DiabetesTrauma, Hemostasis, Coagulopathy, Resuscitation